Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 14, 2006New system enhances diagnosis and treatment of blocked vessels and heart disorders
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its iLab™ Ultrasound Imaging System. Intravascular ultrasound (IVUS)...
-
Jul 12, 2006New Jaw Configuration Designed to Yield Larger Tissue Specimens and Improve Procedural Outcomes
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of the newest version of its Radial Jaw® Single-Use Biopsy Forceps,...
-
Jul 10, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that William E. Young has been appointed Vice President of Quality Assurance and...
-
Jul 10, 2006
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2006...
-
Jun 28, 2006
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of a report from UBS Investment Research that ranked the Company number one in...
-
Jun 26, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it is providing safety information and retrieving a specific subset of pacemakers,...
-
Jun 23, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Jefferies Life Sciences Conference, which is being held June 27 - 28...
-
Jun 15, 2006
Boston Scientific Corporation (NYSE: BSX) announced that the U.S. District Court in Delaware issued a ruling upholding a July 2005 jury verdict in...
-
Jun 12, 2006Boston Scientific's TAXUS stent system used in more complex lesions than J&J's Cypher
Boston Scientific Corporation (NYSE: BSX) welcomed results from the independent, multi-center STENT registry, the largest prospective, comparative...
-
Jun 9, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June...
-
Jun 9, 2006
Boston Scientific Corporation (NYSE: BSX) announced today the completion of a public offering of $1.2 billion aggregate principal amount of its...
-
Jun 6, 2006
Boston Scientific Corporation (NYSE: BSX) announced today the pricing of a public offering of $1.2 billion aggregate principal amount of its senior...
-
Jun 6, 2006Technology Features Powerful Combination of Deliverability and Trackability to Enhance Clinical Versatility
Boston Scientific Corporation (NYSE: BSX) today announced that it has received FDA clearance to launch its Sterling™ Monorail® and Over-the-Wire...
-
May 31, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market...
-
May 26, 2006
Boston Scientific Corporation (NYSE: BSX) announced today that the Court of Appeals for the Federal Circuit has issued a ruling upholding a trial...
-
May 22, 2006Researchers say novel visualization capability may reduce common need for repeat procedures
Boston Scientific Corporation (NYSE: BSX) today announced favorable results from an investigator initiated first human use...
-
May 20, 2006Trial Advances Understanding of Dual-chamber Pacing for Patients at Risk of Sudden Cardiac Death
Boston Scientific Corporation (NYSE: BSX) today reported that the INTRINSIC RV investigative team presented results of a clinical trial designed to...
-
May 19, 2006LATITUDE® Patient Management System Aligns Closely with Recent ACC/AHA Guidelines on Managing Heart Failure
Boston Scientific Corporation (NYSE: BSX) today announced the launch of two large-scale clinical studies to evaluate the benefits of the LATITUDE®...
-
May 18, 2006Physician Society Draft Recommendations Reinforce LATITUDE Active Monitoring ™ Capabilities
Boston Scientific Corporation (NYSE: BSX) today announced the one-year anniversary of the company's first implant of the CONTAK RENEWAL® RF family...
-
May 18, 2006Boston Scientific to Release Broad Range of Clinical Results on Endoscopic Technologies at DDW® 2006Physicians offer preview of SpyGlass™ Direct Visualization System
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at Digestive Disease...
-
May 17, 2006New second-generation training center in Brussels to help medical professionals advance standard of patient care
Boston Scientific Corporation (NYSE: BSX) today announced plans for the construction of a new state-of-the art medical training facility in...
-
May 17, 2006TAXUS benefits demonstrated in non-diabetic patient population carry over into insulin-treated diabetic patients
EuroIntervention, the peer-reviewed medical journal affiliated with the Paris Course on Revascularization, today released an integrated...
-
May 16, 2006TAXUS VI results support positive safety and efficacy profile
Boston Scientific Corporation (NYSE: BSX) today announced three-year follow-up data from its TAXUS VI clinical trial. The data...
-
May 16, 2006Boston Scientific's second generation stent compares favorably to market leading TAXUS Express2™ stent system, even with more complex lesions
Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from its TAXUS ATLAS clinical trial. The results confirmed...
-
May 16, 2006
Boston Scientific Corporation (NYSE: BSX) today announced 12-month data from its MELODIE clinical trial. The trial demonstrates the...